EXEL

EXELIXIS, INC.

Biological Products, (No Diagnostic Substances) · SIC 2836CIK 939767Held by 6 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:X LINKEDIN EMAIL

6 managers · Q2 2026 13F

13F bookWeight

Fuller & Thaler Asset Management

Fuller & Thaler Asset ManagementPosition history →

1.3%

+4.5%

$485.8M

$36.70B13F book · 2026-06-30

Renaissance Technologies

Renaissance TechnologiesPosition history →

1.0%

(2.2%)

$730.6M

$72.62B13F book · 2026-06-30

Bridgewater Associates

Bridgewater AssociatesPosition history →

0.09%

(16.7%)

$21.8M

$24.38B13F book · 2026-06-30

Motley Fool Asset Management

Motley Fool Asset ManagementPosition history →

0.02%

(6.7%)

$0.5M

$2.59B13F book · 2026-06-30

Alps Advisors

Alps AdvisorsPosition history →

<0.01%

+1.3%

$0.7M

$21.33B13F book · 2026-06-30

First Eagle Investment Management

First EaglePosition history →

<0.01%

—

$0.5M

$60.75B13F book · 2026-06-30

Weight = position value ÷ the manager's total 13F long-equity value in the same filing — one definition for every row. “1st obs.” marks a position with no earlier stored 13F to compare against — it is not shown as a purchase.